Urgent.News

What's breaking now, across thousands of outlets.

More in Finance & Markets

MaxCyte To Acquire Akron

(RTTNews) - MaxCyte, Inc. (MXCT) has entered into a definitive agreement to acquire Akron BioProducts LLC from affiliates of Arcline Investment Management for total consideration of $151.8 million.

More from Tuesday 10 November →